电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant KRT8 抗体

This anti-KRT8 antibody is a 兔 单克隆 antibody detecting KRT8 in WB, IF, FACS 和 IHC (f). Suitable for 人.
产品编号 ABIN7126623
发货至: 中国

Quick Overview for Recombinant KRT8 抗体 (ABIN7126623)

抗原

See all KRT8 抗体
KRT8 (Keratin 8 (KRT8))

抗体类型

Recombinant Antibody

适用

  • 314
  • 89
  • 78
  • 67
  • 65
  • 63
  • 62
  • 16
  • 14
  • 10
  • 8
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1

宿主

  • 169
  • 162
  • 3

克隆类型

  • 184
  • 147
  • 1
单克隆

标记

  • 172
  • 27
  • 17
  • 12
  • 9
  • 8
  • 8
  • 8
  • 8
  • 8
  • 8
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This KRT8 antibody is un-conjugated

应用范围

  • 239
  • 176
  • 123
  • 88
  • 71
  • 49
  • 48
  • 42
  • 41
  • 40
  • 37
  • 28
  • 22
  • 5
  • 5
  • 4
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • 特异性

    Epitope of this MAb is located between aa343-357. Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular ( ring-like, perinuclear ) from ductal ( peripheral-predominant ) carcinoma of the breast.

    交叉反应 (详细)

    Human. Does not react with rat.

    纯化方法

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    免疫原

    Keratin preparation from a human carcinoma

    亚型

    IgG
  • 应用备注

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (2-4 μg/mL), ,Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: HCT116, MCF-7, HeLa or A431 cells. Human skin, colon, lung or breast carcinoma.

    限制

    仅限研究用
  • 浓度

    1.0 mg/mL

    缓冲液

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    储存液

    Azide free

    储存条件

    -20 °C,-80 °C

    储存方法

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    有效期

    24 months
  • 抗原

    KRT8 (Keratin 8 (KRT8))

    别名

    KRT8

    背景

    CARD2, CK8, CYK8, CYKER, Cytokeratin Endo A, DreK8, EndoA, K2C8, K8, Keratin 8, Krt 2.8, KRT8, Type-II Keratin Kb8,Cytokeratin 8 (KRT8)
    Cellular localisation: Cytoplasmic

    分子量

    52.5kDa

    基因ID

    3856

    UniProt

    P05787
You are here:
Chat with us!